Bcwm LLC Takes $935,000 Position in Heartflow, Inc. $HTFL

Bcwm LLC purchased a new position in Heartflow, Inc. (NASDAQ:HTFL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 31,878 shares of the company’s stock, valued at approximately $935,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HTFL. Caitong International Asset Management Co. Ltd purchased a new position in Heartflow during the fourth quarter valued at $27,000. Russell Investments Group Ltd. bought a new stake in Heartflow in the fourth quarter worth $45,000. Essential Partners LLC purchased a new stake in shares of Heartflow in the first quarter worth $57,000. Legal & General Group Plc bought a new position in shares of Heartflow during the third quarter valued at $59,000. Finally, Strs Ohio bought a new position in shares of Heartflow during the fourth quarter valued at $99,000.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HTFL shares. Wells Fargo & Company upped their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Piper Sandler restated an “overweight” rating and set a $45.00 price objective (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. William Blair assumed coverage on shares of Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. increased their price target on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Heartflow currently has a consensus rating of “Moderate Buy” and an average target price of $43.43.

Insider Transactions at Heartflow

In other news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the sale, the insider directly owned 86,459 shares in the company, valued at $3,564,704.57. The trade was a 9.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 27,230 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the transaction, the chief executive officer directly owned 360,814 shares of the company’s stock, valued at $18,040,700. The trade was a 7.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 191,271 shares of company stock worth $7,089,136. Insiders own 7.70% of the company’s stock.

Heartflow Price Performance

Shares of NASDAQ:HTFL opened at $48.94 on Thursday. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $51.19. The company has a market cap of $4.26 billion and a P/E ratio of -26.74. The stock’s fifty day moving average price is $31.68 and its 200-day moving average price is $28.79.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company had revenue of $64.08 million during the quarter. The company’s revenue for the quarter was up 47.7% on a year-over-year basis. On average, sell-side analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.